Nippon Paper Industries Co (3863) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
19 Aug, 2025Executive summary
Net sales rose 1.3% year-over-year to ¥1,182.4 billion, driven by growth in household paper, healthcare, and chemicals.
Operating income increased 14.1% year-over-year to ¥19.7 billion, supported by strong domestic daily-life products and energy businesses.
Net income attributable to owners of parent dropped 80% year-over-year to ¥4.5 billion due to impairment losses, but exceeded initial forecasts thanks to asset sales.
Comprehensive income fell sharply to ¥17,259 million from ¥82,102 million in the prior year.
Financial highlights
EBITDA reached ¥90.7 billion, up from ¥84.8 billion the previous year.
Basic earnings per share declined to ¥39.33 from ¥197.09 year-over-year.
ROE declined to 1.0% from 5.3% year-over-year.
Free cash flow decreased to ¥39.3 billion from ¥68.2 billion year-over-year.
Net assets rose to ¥510,435 million, with a capital adequacy ratio of 28.3%.
Outlook and guidance
FY2026/3 forecast projects net sales of ¥1,205.0 billion (+1.9%), operating income of ¥34.0 billion (+72.5%), and net income of ¥12.0 billion (+164.4%) year-over-year.
Growth expected from increased sales volume and price adjustments in domestic daily-life products and improved overseas profitability.
Annual dividend forecast is ¥15.00 per share.
Opal anticipates an extraordinary loss due to labor disputes and operational suspension in Q1.
Latest events from Nippon Paper Industries Co
- Operating and net income surged, driven by Daily-Life Products and overseas recovery.3863
Q3 20266 Feb 2026 - Profit rebounded in H1 FY2026/3, but full-year outlook trimmed on weak export and Australia demand.3863
Q2 20266 Nov 2025 - Operating income soared and net loss narrowed, with major restructuring and bond issuance planned.3863
Q1 202519 Aug 2025 - Sales and profits increased, with sustainability investments and a return to profitability.3863
Q3 202519 Aug 2025 - Sales were stable but profits fell sharply; H2 recovery expected, led by overseas operations.3863
Q2 202519 Aug 2025 - Earnings rose on Daily-Life Products and Energy growth, but FX losses weighed on comprehensive income.3863
Q1 202619 Aug 2025